Skip To Main Content
Hematologic Genetic Diseases on Muck Rack

Hematologic Genetic Diseases

As seen in: Nature, Diabetes Care Magazine, ASN Journals
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Hematologic Genetic

Contact Hematologic Genetic, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Could a Pragmatic Detection Strategy Be the Gateway for Effective Population Health for CKD?

|
By Jenna M Norton, Hematologic Genetic Diseases, Andrew S. Narva, Urban Sustainability
| ASN Journals Verified
The ongoing coronavirus disease 2019 pandemic has strained our healthcare system to its breaking point and, along with the rising awareness of racial injustice in our country, has shaken many widely held assumptions about the equity of our health system. As we question our longstanding assumptions
Open in Who Shared Issue with article?

Protecting the kidney in systemic lupus erythematosus: from diagnosis to therapy

|
By Naomi I Maria, Anne Davidson, Hematologic Genetic Diseases
| Nature Verified
1. Almaani, S., Meara, A. & Rovin, B. H. Update on lupus nephritis. Clin. J. Am. Soc. Nephrol. 12, 825–835 (2017). PubMed Article PubMed Central Google Scholar 2. Brunner, H. I., Gladman, D. D., Ibanez, D., Urowitz, M. D. & Silverman, E. D. Difference in disease features between childhood-onset and adult-onset systemic lupus erythematosus. Arthritis Rheum. 58, 556–562 (2008). PubMed Article PubMed Central Google Scholar 3. Hoover, P. J. & Costenbader, K. H.
Open in Who Shared Issue with article?

Preventing Early Renal Loss in Diabetes (PERL) Study: A Randomized Double-Blinded Trial of Allopurinol-Rationale, Design, and Baseline Data

|
By Maryam Afkarian, Sarit Polsky, Hematologic Genetic Diseases, Afshin Parsa
| Diabetes Care Magazine Verified
Emerging Therapies: Drugs and Regimens Abstract OBJECTIVE Higher serum uric acid (SUA) is associated with diabetic kidney disease (DKD). Preventing Early Renal Loss in Diabetes (PERL) evaluates whether lowering SUA with allopurinol slows glomerular filtration rate (GFR) loss in people with type 1 diabetes (T1D) and mild to moderate DKD. We present the PERL rationale, design, and baseline characteristics.
Open in Who Shared Issue with article?
See all 4 articles